Gefitinib

Especificaciones

184475-35-2Número CAS

643-034-7Número CE

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amineNombre IUPAC

C22H24ClFN4O3Fórmula química

446.9 g/molPeso molecular

Gefitinib; 184475-35-2; Iressa; ZD1839; Irressat; ZD-1839; ZD 1839; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine; gefitinibum; DTXSID8041034; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline; NSC-759856; S65743JHBS; DTXCID6021034; CHEBI:49668; NSC715055; 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(morpholin-4-yl)propoxy)quinazolin-4-amine; RefChem:58462; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide; L01XE02; N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholin) propoxy)-4-quinazolinamine; 643-034-7; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; gefitinib (zd1839); C22H24ClFN4O3; Gefitinib (GMP); MFCD04307832; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; CHEMBL939; 3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline; Gefitinib [USAN]; NCGC00159455-02; N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine; Iressa(TM); (3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE; IRE; Iressa (TN); CCRIS 9011; CAS-184475-35-2; SR-00000000262; gefitnib; gifitinib; UNII-S65743JHBS; Gefitinib [USAN:INN:BAN]; Irressat;; Gefitinib CRS; Iressa;; Gefitini; Iressa; GefitinibZD1839; Gefitinib (Standard); Iressa (AstraZeneca); nchembio866-comp14; Kinome_3321; Kinome_3322; GEFITINIB [INN]; GEFITINIB [JAN]; GEFITINIB [MI]; GEFITINIB [VANDF]; Gefitinib (ZD1839)?; GEFITINIB [MART.]; GEFITINIB [WHO-DD]; SCHEMBL7866; Gefitinib,ZD-1839,Iressa; GEFITINIB [EMA EPAR]; KBioSS_002241; MLS003899193; CU-00000000396-1; Gefitinib - Bio-X trade mark; BDBM5447; cid_123631; GTPL4941; orb1309499; orb3141272; SCHEMBL4535121; SCHEMBL4535128; SCHEMBL4535134; Gefitinib (JP18/USAN/INN); GEFITINIB [ORANGE BOOK]; GEFITINIB [EP MONOGRAPH]; Gefitinib, >=98% (HPLC); SCHEMBL29351046; SCHEMBL29351336; GLXC-05820; HMS2089B19; HMS3244M21; HMS3244M22; HMS3244N21; HMS3295A21; HMS3413H08; HMS3654A07; HMS3677H08; HMS3714A05; HMS3748E17; HMS5079C05; Pharmakon1600-01502274; YWB97640; Tox21_111683; BDBM50338602; EBC-07543; Gefitinib for system suitability CRS; HY-50895G; HY-50895R; MSK159193; NSC759856; NSC800105; s1025; STK621310; AKOS000280752; Tox21_111683_1; AB20814; AC-1556; CCG-220642; CS-0124; DB00317; FG10816; KS-1204; NSC 759856; NSC-715055; NSC-800105; SDCCGSBI-0634411.P005; 4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline; 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-; 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine; NCGC00159455-03; NCGC00159455-04; NCGC00159455-05; NCGC00159455-06; NCGC00159455-08; NCGC00159455-09; NCGC00159455-14; NCGC00159455-26; BCB03_000781; BG164498; HY-50895; SMR002204119; SY002154; CS-0622782; G0546; G1721; NS00006312; SW199108-4; D01977; EN300-123024; G-4408; K00240; AB01273954-01; AB01273954-02; AB01273954-03; AB01273954_04; F079438; Q417824; SR-00000000262-2; SR-00000000262-3; BRD-K64052750-001-16-7; BRD-K64052750-001-17-5; BRD-K64052750-001-22-5; BRD-K64052750-001-23-3; Gefitinib, EuropePharmacopoeia (EP) Reference Standard; Z1546610485; (3-Chloro-4-fluoro-phenyl)-[7-methoxy-6-(2-morpholin-4-yl-ethoxy)-quinazolin-4-yl]-amine; 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)-quinazoline; Gefitinib for system suitability, EuropePharmacopoeia (EP) Reference Standard; N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4 -ylpropoxy)quinazolin-4-amineSinónimos